CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

travoprost ophthalmic solution

Last Updated: January 31, 2017
Result type: Reports
Project Number: SR0516-000
Product Line: Common Drug Review

Generic Name: travoprost ophthalmic solution

Brand Name: Izba

Manufacturer: Novartis Pharmaceuticals Canada Inc.

Indications: open-angle glaucoma

Submission Type: New

Project Status: Complete

Date Recommendation Issued: October 25, 2017

Recommendation Type: Reimburse with clinical criteria and/or conditions